Here, we showed the independent predictive value of the ICR signature for efficacy of single-agent anti-PD1/PDL1 ICI in the largest retrospective multicentric clinical reported cohort of patients with NSCLC. The gene discussed is CD274; the disease is non-small cell lung carcinoma.